NCT06952660 2026-03-12Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPfizerPhase 4 Recruiting100 enrolled
NCT06586957 2026-02-11A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsNiKang Therapeutics, Inc.Phase 1 Recruiting150 enrolled